InsidersTradesSigma
Track the Natco Pharma stock price and the full directors' dealings record of the company, a listed equity based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Market capitalisation: €151.4bn. The latest transaction was filed on 26 August 2026 (Disposal). Among the most active insiders: DURGA DEVI NANNAPANENI. Every trade is free.
1
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
Fundamental score
Ranked 761 of 29,063 companies
82.6
score / 100
Value77
Quality88
FCF yld9.1%
Earn yld9.4%
EV/EBITDA9.1x
ROE19%
Gross mgn83%
Net mgn35%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 August 2026
Declarations1 total
50,000 shares0EquityGiftSEBI:11857c7fc4889db2a2f9d24a2cf794bd54708087
1 of 1 declaration
About Natco Pharma
Natco Pharma is an Indian pharmaceutical company focused on the research, development, and manufacturing of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.